The cardiovascular risk profile of middle age women previously diagnosed with premature ovarian insufficiency: A case-control study.
BACKGROUND:Cardiovascular disease (CVD) is the leading cause of death in women worldwide. The cardiovascular risk profile deteriorates after women enter menopause. By definition, women diagnosed with premature ovarian insufficiency (POI) experience menopause before 40 years of age, which may render...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0229576 |
id |
doaj-da2e10c0ac5444bcbf70f65793a3e0ec |
---|---|
record_format |
Article |
spelling |
doaj-da2e10c0ac5444bcbf70f65793a3e0ec2021-03-03T21:34:18ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-01153e022957610.1371/journal.pone.0229576The cardiovascular risk profile of middle age women previously diagnosed with premature ovarian insufficiency: A case-control study.Marlise N GunningCindy MeunBas B van RijnNadine M P DaanJeanine E Roeters van LennepYolande AppelmanEric BoersmaLeonard HofstraClemens G K M FauserOscar L Rueda-OchoaMohammad A IkramMaryam KavousiCornelis B LambalkMarinus J C EijkemansJoop S E LavenBart C J M FauserCREW consortiumBACKGROUND:Cardiovascular disease (CVD) is the leading cause of death in women worldwide. The cardiovascular risk profile deteriorates after women enter menopause. By definition, women diagnosed with premature ovarian insufficiency (POI) experience menopause before 40 years of age, which may render these women even more susceptible to develop CVD later in life. However, prospective long-term follow up data of well phenotyped women with POI are scarce. In the current study we compare the CVD profile and risk of middle aged women previously diagnosed with POI, to a population based reference group matched for age and BMI. METHODS AND FINDINGS:We compared 123 women (age 49.0 (± 4.3) years) and diagnosed with POI 8.1 (IQR: 6.8-9.6) years earlier, with 123 population controls (age 49.4 (± 3.9) years). All women underwent an extensive standardized cardiovascular screening. We assessed CVD risk factors including waist circumference, BMI, blood pressure, lipid profile, pulse wave velocity (PWV), and the prevalence of diabetes mellitus, metabolic syndrome (MetS) and carotid intima media thickness (cIMT), in both women with POI and controls. We calculated the 10-year CVD Framingham Risk Score (FRS) and the American Heart Association's suggested cardiovascular health score (CHS). Waist circumference (90.0 (IQR: 83.0-98.0) versus 80.7 (IQR: 75.1-86.8), p < 0.01), waist-to-hip ratio (0.90 (IQR: 0.85-0.93) versus 0.79 (IQR: 0.75-0.83), p < 0.01), systolic blood pressure (124 (IQR 112-135) versus 120 (IQR109-131), p < 0.04) and diastolic blood pressure (81 (IQR: 76-89) versus 78 (IQR: 71-86), p < 0.01), prevalence of hypertension (45 (37%) versus 21 (17%), p < 0.01) and MetS (19 (16%) versus 4 (3%), p < 0.01) were all significantly increased in women with POI compared to healthy controls. Other risk factors, however, such as lipids, glucose levels and prevalence of diabetes were similar comparing women with POI versus controls. The arterial stiffness assessed by PWV was also similar in both populations (8.1 (IQR: 7.1-9.4) versus 7.9 (IQR: 7.1-8.4), p = 0.21). In addition, cIMT was lower in women with POI compared to controls (550 μm (500-615) versus 684 μm (618-737), p < 0.01). The calculated 10-year CVD risk was 5.9% (IQR: 3.7-10.6) versus 6.0% (IQR: 3.9-9.0) (p = 0.31) and current CHS was 6.1 (1.9) versus 6.5 (1.6) (p = 0.07), respectively in POI versus controls. CONCLUSIONS:Middle age women with POI presented with more unfavorable cardiovascular risk factors (increased waist circumference and a higher prevalence of hypertension and MetS) compared to age and BMI matched population controls. In contrast, the current study reveals a lower cIMT and similar 10-year cardiovascular disease risk and cardiovascular health score. In summary, neither signs of premature atherosclerosis nor a worse cardiovascular disease risk or health score were observed among middle age women with POI compared to population controls. Longer-term follow-up studies of women of more advanced age are warranted to establish whether women with POI are truly at increased risk of developing CVD events later in life. TRIAL REGISTRATION:ClinicalTrials.gov Identifier: NCT02616510.https://doi.org/10.1371/journal.pone.0229576 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Marlise N Gunning Cindy Meun Bas B van Rijn Nadine M P Daan Jeanine E Roeters van Lennep Yolande Appelman Eric Boersma Leonard Hofstra Clemens G K M Fauser Oscar L Rueda-Ochoa Mohammad A Ikram Maryam Kavousi Cornelis B Lambalk Marinus J C Eijkemans Joop S E Laven Bart C J M Fauser CREW consortium |
spellingShingle |
Marlise N Gunning Cindy Meun Bas B van Rijn Nadine M P Daan Jeanine E Roeters van Lennep Yolande Appelman Eric Boersma Leonard Hofstra Clemens G K M Fauser Oscar L Rueda-Ochoa Mohammad A Ikram Maryam Kavousi Cornelis B Lambalk Marinus J C Eijkemans Joop S E Laven Bart C J M Fauser CREW consortium The cardiovascular risk profile of middle age women previously diagnosed with premature ovarian insufficiency: A case-control study. PLoS ONE |
author_facet |
Marlise N Gunning Cindy Meun Bas B van Rijn Nadine M P Daan Jeanine E Roeters van Lennep Yolande Appelman Eric Boersma Leonard Hofstra Clemens G K M Fauser Oscar L Rueda-Ochoa Mohammad A Ikram Maryam Kavousi Cornelis B Lambalk Marinus J C Eijkemans Joop S E Laven Bart C J M Fauser CREW consortium |
author_sort |
Marlise N Gunning |
title |
The cardiovascular risk profile of middle age women previously diagnosed with premature ovarian insufficiency: A case-control study. |
title_short |
The cardiovascular risk profile of middle age women previously diagnosed with premature ovarian insufficiency: A case-control study. |
title_full |
The cardiovascular risk profile of middle age women previously diagnosed with premature ovarian insufficiency: A case-control study. |
title_fullStr |
The cardiovascular risk profile of middle age women previously diagnosed with premature ovarian insufficiency: A case-control study. |
title_full_unstemmed |
The cardiovascular risk profile of middle age women previously diagnosed with premature ovarian insufficiency: A case-control study. |
title_sort |
cardiovascular risk profile of middle age women previously diagnosed with premature ovarian insufficiency: a case-control study. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2020-01-01 |
description |
BACKGROUND:Cardiovascular disease (CVD) is the leading cause of death in women worldwide. The cardiovascular risk profile deteriorates after women enter menopause. By definition, women diagnosed with premature ovarian insufficiency (POI) experience menopause before 40 years of age, which may render these women even more susceptible to develop CVD later in life. However, prospective long-term follow up data of well phenotyped women with POI are scarce. In the current study we compare the CVD profile and risk of middle aged women previously diagnosed with POI, to a population based reference group matched for age and BMI. METHODS AND FINDINGS:We compared 123 women (age 49.0 (± 4.3) years) and diagnosed with POI 8.1 (IQR: 6.8-9.6) years earlier, with 123 population controls (age 49.4 (± 3.9) years). All women underwent an extensive standardized cardiovascular screening. We assessed CVD risk factors including waist circumference, BMI, blood pressure, lipid profile, pulse wave velocity (PWV), and the prevalence of diabetes mellitus, metabolic syndrome (MetS) and carotid intima media thickness (cIMT), in both women with POI and controls. We calculated the 10-year CVD Framingham Risk Score (FRS) and the American Heart Association's suggested cardiovascular health score (CHS). Waist circumference (90.0 (IQR: 83.0-98.0) versus 80.7 (IQR: 75.1-86.8), p < 0.01), waist-to-hip ratio (0.90 (IQR: 0.85-0.93) versus 0.79 (IQR: 0.75-0.83), p < 0.01), systolic blood pressure (124 (IQR 112-135) versus 120 (IQR109-131), p < 0.04) and diastolic blood pressure (81 (IQR: 76-89) versus 78 (IQR: 71-86), p < 0.01), prevalence of hypertension (45 (37%) versus 21 (17%), p < 0.01) and MetS (19 (16%) versus 4 (3%), p < 0.01) were all significantly increased in women with POI compared to healthy controls. Other risk factors, however, such as lipids, glucose levels and prevalence of diabetes were similar comparing women with POI versus controls. The arterial stiffness assessed by PWV was also similar in both populations (8.1 (IQR: 7.1-9.4) versus 7.9 (IQR: 7.1-8.4), p = 0.21). In addition, cIMT was lower in women with POI compared to controls (550 μm (500-615) versus 684 μm (618-737), p < 0.01). The calculated 10-year CVD risk was 5.9% (IQR: 3.7-10.6) versus 6.0% (IQR: 3.9-9.0) (p = 0.31) and current CHS was 6.1 (1.9) versus 6.5 (1.6) (p = 0.07), respectively in POI versus controls. CONCLUSIONS:Middle age women with POI presented with more unfavorable cardiovascular risk factors (increased waist circumference and a higher prevalence of hypertension and MetS) compared to age and BMI matched population controls. In contrast, the current study reveals a lower cIMT and similar 10-year cardiovascular disease risk and cardiovascular health score. In summary, neither signs of premature atherosclerosis nor a worse cardiovascular disease risk or health score were observed among middle age women with POI compared to population controls. Longer-term follow-up studies of women of more advanced age are warranted to establish whether women with POI are truly at increased risk of developing CVD events later in life. TRIAL REGISTRATION:ClinicalTrials.gov Identifier: NCT02616510. |
url |
https://doi.org/10.1371/journal.pone.0229576 |
work_keys_str_mv |
AT marlisengunning thecardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT cindymeun thecardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT basbvanrijn thecardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT nadinempdaan thecardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT jeanineeroetersvanlennep thecardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT yolandeappelman thecardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT ericboersma thecardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT leonardhofstra thecardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT clemensgkmfauser thecardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT oscarlruedaochoa thecardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT mohammadaikram thecardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT maryamkavousi thecardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT cornelisblambalk thecardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT marinusjceijkemans thecardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT joopselaven thecardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT bartcjmfauser thecardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT crewconsortium thecardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT marlisengunning cardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT cindymeun cardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT basbvanrijn cardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT nadinempdaan cardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT jeanineeroetersvanlennep cardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT yolandeappelman cardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT ericboersma cardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT leonardhofstra cardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT clemensgkmfauser cardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT oscarlruedaochoa cardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT mohammadaikram cardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT maryamkavousi cardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT cornelisblambalk cardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT marinusjceijkemans cardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT joopselaven cardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT bartcjmfauser cardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy AT crewconsortium cardiovascularriskprofileofmiddleagewomenpreviouslydiagnosedwithprematureovarianinsufficiencyacasecontrolstudy |
_version_ |
1714816310585589760 |